: MHC class II molecules present peptides derived from self and foreign antigens to CD4+ T-cells. Peptides derived from exogenous antigens and proteins localized in endosomes, are captured by class II dimers as these MHC molecules transit to the cell surface. Remarkably, epitopes from select cytoplasmic antigens also gain access to class II proteins. Cytoplasmic antigens have long been viewed as the primary source of peptides for MHC class molecules. Yet mechanisms appear to have evolved to allow class II proteins to sample select peptides within the cytoplasm, potentiating helper T-cell responses to intracellular pathogens, tumors and the maintenance of self tolerance. The purpose of this application is to elucidate the pathway(s) required for processing and delivery of cytoplasmic antigens to MHC class II proteins. We hypothesized that proteases in the cytoplasm regulate epitope abundance, with a subset of the resulting peptides being directly translocated into membrane organelles for binding to class II molecules. Indeed, neutral proteases within the cytoplasm can modulate epitope production for class II restricted presentation.
In aim 1, studies are proposed to further identify these proteases and to define their regulation in APC. Class II-restricted presentation of exogenous antigens is controlled by co-factors such as the Invariant chain, DM and DO.
In aim 2, the importance of these accessory molecules in cytoplasmic antigen presentation will be examined. As these co-factors associate with class II proteins in distinct membrane organelles, elucidating their role in cytoplasmic antigen presentation will help dissect the relative importance of the endoplasmic reticulum vs. endosomes in this novel class II pathway. Studies also suggest that translocation of cytoplasmic epitopes into distinct membrane organelles must occur to deliver these ligands to class II molecules. Yet, the essential features guiding cytoplasmic epitope translocation to receptive class II proteins, remain undefined.
In aim 3, experiments to elucidate the role of peptide transporters and heat shock proteins in cytoplasmic antigen presentation via MHC class II molecules are therefore proposed. These studies will provide key insights into this novel pathway for class II presentation with implications for vaccine development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI049589-03
Application #
6632342
Study Section
Immunobiology Study Section (IMB)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2001-06-01
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
3
Fiscal Year
2003
Total Cost
$331,410
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Crotzer, Victoria L; Glosson, Nicole; Zhou, Delu et al. (2010) LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens. Immunology 131:318-30
Crotzer, Victoria L; Blum, Janice S (2009) Autophagy and its role in MHC-mediated antigen presentation. J Immunol 182:3335-41
Wang, Nan; Weber, Ekkehard; Blum, Janice S (2009) Diminished intracellular invariant chain expression after vaccinia virus infection. J Immunol 183:1542-50
Houlihan, Josetta L; Metzler, Jennifer J; Blum, Janice S (2009) HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells. J Immunol 182:7451-8
Strawbridge, Andrew B; Blum, Janice S (2007) Autophagy in MHC class II antigen processing. Curr Opin Immunol 19:87-92
Haque, Azizul; Hajiaghamohseni, Laela M; Li, Ping et al. (2007) Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cell Immunol 249:20-9
Li, Ping; Wang, Nan; Zhou, Delu et al. (2005) Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J Immunol 175:6481-8
O'Donnell, Patrick W; Haque, Azizul; Klemsz, Michael J et al. (2004) Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. J Immunol 173:731-5
Wong, Athena W; Brickey, W June; Taxman, Debra J et al. (2003) CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nat Immunol 4:891-8
Lich, John D; Jayne, Jennifer A; Zhou, Delu et al. (2003) Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J Immunol 171:853-9